{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:13:29Z","timestamp":1788261209694,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.antiviral.2003.07.004","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T21:11:43Z","timestamp":1063746703000},"page":"209-219","source":"Crossref","is-referenced-by-count":99,"title":["Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus"],"prefix":"10.1016","volume":"60","author":[{"given":"Koen","family":"Andries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Moeremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Gevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Willebrords","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cois","family":"Sommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lacrampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R","family":"Wyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2003.07.004_BIB1","unstructured":"Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Lacrampe, J., Janssens, F., 2000. R170591, a novel fusion inhibitor with picomolar activity against respiratory syncytial virus (RSV). Abstract 11640th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17\u201320 September 2000."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB2","unstructured":"Anonymous, 1996. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 97 (1), 137\u2013140."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/viro.1997.8582","article-title":"Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin","volume":"232","author":"Bitko","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0042-6822(80)90207-X","article-title":"Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane","volume":"103","author":"Dubovi","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI1355","article-title":"Local and systemic cytokine responses during experimental human influenza A virus infection","volume":"101","author":"Hayden","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.antiviral.2003.07.004_BIB6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/314938","article-title":"Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment","volume":"180","author":"Hayden","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2003.07.004_BIB7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.46.3.841-847.2002","article-title":"RFI-641, a potent respiratory syncytial virus inhibitor","volume":"46","author":"Huntley","year":"2002","journal-title":"Antimicrobial Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2003.07.004_BIB8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(00)00091-7","article-title":"Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo","volume":"47","author":"Kimura","year":"2000","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.antiviral.2003.07.004_BIB9","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-0934(91)90154-R","article-title":"Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients","volume":"31","author":"Mbiguino","year":"1991","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB11","unstructured":"McKimm-Breschkin, J., 2000. VP-1463ViroPharma. Curr. Opin. Invest. Drugs 1 (4), 425\u2013427."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB13","first-page":"L472","article-title":"Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line","volume":"265","author":"Noah","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.antiviral.2003.07.004_BIB14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1074-5521(01)00042-4","article-title":"RFI-64inhibits entry of respiratory syncytial virus via interactions with fusion protein","volume":"8","author":"Razinkov","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-0934(98)00167-0","article-title":"Quantitative sense-specific determination of murine coronavirus RNA by reverse transcription polymerase chain reaction","volume":"78","author":"Schoenike","year":"1999","journal-title":"J. Virol. Methods"},{"issue":"5","key":"10.1016\/j.antiviral.2003.07.004_BIB16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/protein\/15.5.365","article-title":"Modelling the structure of the fusion protein from human respiratory syncytial virus","volume":"15","author":"Smith","year":"2002","journal-title":"Protein Eng."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB17","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/JVI.65.8.4063-4069.1991","article-title":"Characteristics of fusion of respiratory syncytial virus with HEp-cells as measured by R1 fluorescence dequenching assay","volume":"65","author":"Srinivasakumar","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB18","doi-asserted-by":"crossref","unstructured":"The IMpact-RSV Study Group, 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102 (Pt 1), 531\u2013537.","DOI":"10.1542\/peds.102.3.531"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB19","doi-asserted-by":"crossref","unstructured":"Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N., Anderson, L.J., Fukuda, K., 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289, 179\u2013186.","DOI":"10.1001\/jama.289.2.179"},{"issue":"3","key":"10.1016\/j.antiviral.2003.07.004_BIB20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1998.9222","article-title":"Novel anti-respiratory syncytial (RS) viral compounds: benzodithiin derivatives","volume":"249","author":"Watanabe","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(95)91615-6","article-title":"RSV and chronic asthma","volume":"346","author":"Welliver","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2003.07.004_BIB22","unstructured":"Wyde, P.R., Chetty, S.N., Timmerman, P., Gilbert, B.E., Andries, K., in press. Short duration aerosols of JNJ 240806 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Res."},{"key":"10.1016\/j.antiviral.2003.07.004_BIB23","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Luxon, B.A., Casola, A., Garofalo, R.P., Jamaluddin, M., Brasier, A.R., 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75 (19), 9044\u20139058.","DOI":"10.1128\/JVI.75.19.9044-9058.2001"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354203001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354203001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T15:50:57Z","timestamp":1585151457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354203001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0166354203001797"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2003.07.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}